Report Detail
Global (United States, European Union and China) Monoclonal Antibodies Market Research Report 2019-2025
- RnM3712863 |
- 30 August, 2019 |
- Global |
- 128 Pages |
- QYResearch |
- Pharma & Healthcare
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
In 2019, the market size of Monoclonal Antibodies is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Monoclonal Antibodies.
This report studies the global market size of Monoclonal Antibodies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Monoclonal Antibodies sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AbbVie
Roche
Johnson & Johnson
Amgen
Merck
BMS
Eli Lilly
Formation Biologics
Genmab
GlaxoSmithKline
Human Genome Sciences
mmunogen
MedImmune
Novartis
Pfizer
Seattle Genetics
Stemcentrx
Synthon Biopharmaceuticals
Takeda
Teva
Market Segment by Product Type
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others
Market Segment by Application
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Monoclonal Antibodies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Monoclonal Antibodies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Monoclonal Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Cancer
- 1.3.3 Autoimmune Diseases
- 1.3.4 Infection
- 1.3.5 Hematological Diseases
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Monoclonal Antibodies Market Share by Application (2019-2025)
- 1.4.2 Oncology
- 1.4.3 Autoimmune and inflammatory diseases
- 1.4.4 Respiratory diseases
- 1.4.5 Ophthalmology
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Monoclonal Antibodies Market Size
- 2.1.1 Global Monoclonal Antibodies Revenue 2014-2025
- 2.1.2 Global Monoclonal Antibodies Sales 2014-2025
- 2.2 Monoclonal Antibodies Growth Rate by Regions
- 2.2.1 Global Monoclonal Antibodies Sales by Regions 2014-2019
- 2.2.2 Global Monoclonal Antibodies Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Monoclonal Antibodies Sales by Manufacturers
- 3.1.1 Monoclonal Antibodies Sales by Manufacturers 2014-2019
- 3.1.2 Monoclonal Antibodies Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Monoclonal Antibodies Revenue by Manufacturers (2014-2019)
- 3.2.2 Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
- 3.3 Monoclonal Antibodies Price by Manufacturers
- 3.4 Key Manufacturers Monoclonal Antibodies Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Monoclonal Antibodies Market
- 3.6 Key Manufacturers Monoclonal Antibodies Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Cancer Sales and Revenue (2014-2019)
- 4.1.2 Autoimmune Diseases Sales and Revenue (2014-2019)
- 4.1.3 Infection Sales and Revenue (2014-2019)
- 4.1.4 Hematological Diseases Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Monoclonal Antibodies Sales Market Share by Type
- 4.3 Global Monoclonal Antibodies Revenue Market Share by Type
- 4.4 Monoclonal Antibodies Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Monoclonal Antibodies Sales by Application
6 United States
- 6.1 United States Monoclonal Antibodies Breakdown Data by Company
- 6.2 United States Monoclonal Antibodies Breakdown Data by Type
- 6.3 United States Monoclonal Antibodies Breakdown Data by Application
7 European Union
- 7.1 European Union Monoclonal Antibodies Breakdown Data by Company
- 7.2 European Union Monoclonal Antibodies Breakdown Data by Type
- 7.3 European Union Monoclonal Antibodies Breakdown Data by Application
8 China
- 8.1 China Monoclonal Antibodies Breakdown Data by Company
- 8.2 China Monoclonal Antibodies Breakdown Data by Type
- 8.3 China Monoclonal Antibodies Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Monoclonal Antibodies Breakdown Data by Company
- 9.2 Rest of World Monoclonal Antibodies Breakdown Data by Type
- 9.3 Rest of World Monoclonal Antibodies Breakdown Data by Application
- 9.4 Rest of World Monoclonal Antibodies Breakdown Data by Countries
- 9.4.1 Rest of World Monoclonal Antibodies Sales by Countries
- 9.4.2 Rest of World Monoclonal Antibodies Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AbbVie
- 10.1.1 AbbVie Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.1.4 Monoclonal Antibodies Product Introduction
- 10.1.5 AbbVie Recent Development
- 10.2 Roche
- 10.2.1 Roche Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.2.4 Monoclonal Antibodies Product Introduction
- 10.2.5 Roche Recent Development
- 10.3 Johnson & Johnson
- 10.3.1 Johnson & Johnson Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.3.4 Monoclonal Antibodies Product Introduction
- 10.3.5 Johnson & Johnson Recent Development
- 10.4 Amgen
- 10.4.1 Amgen Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.4.4 Monoclonal Antibodies Product Introduction
- 10.4.5 Amgen Recent Development
- 10.5 Merck
- 10.5.1 Merck Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.5.4 Monoclonal Antibodies Product Introduction
- 10.5.5 Merck Recent Development
- 10.6 BMS
- 10.6.1 BMS Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.6.4 Monoclonal Antibodies Product Introduction
- 10.6.5 BMS Recent Development
- 10.7 Eli Lilly
- 10.7.1 Eli Lilly Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.7.4 Monoclonal Antibodies Product Introduction
- 10.7.5 Eli Lilly Recent Development
- 10.8 Formation Biologics
- 10.8.1 Formation Biologics Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.8.4 Monoclonal Antibodies Product Introduction
- 10.8.5 Formation Biologics Recent Development
- 10.9 Genmab
- 10.9.1 Genmab Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.9.4 Monoclonal Antibodies Product Introduction
- 10.9.5 Genmab Recent Development
- 10.10 GlaxoSmithKline
- 10.10.1 GlaxoSmithKline Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Monoclonal Antibodies
- 10.10.4 Monoclonal Antibodies Product Introduction
- 10.10.5 GlaxoSmithKline Recent Development
- 10.11 Human Genome Sciences
- 10.12 mmunogen
- 10.13 MedImmune
- 10.14 Novartis
- 10.15 Pfizer
- 10.16 Seattle Genetics
- 10.17 Stemcentrx
- 10.18 Synthon Biopharmaceuticals
- 10.19 Takeda
- 10.20 Teva
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Monoclonal Antibodies Sales Channels
- 11.2.2 Monoclonal Antibodies Distributors
- 11.3 Monoclonal Antibodies Customers
12 Market Forecast
- 12.1 Global Monoclonal Antibodies Sales and Revenue Forecast 2019-2025
- 12.2 Global Monoclonal Antibodies Sales Forecast by Type
- 12.3 Global Monoclonal Antibodies Sales Forecast by Application
- 12.4 Monoclonal Antibodies Forecast by Regions
- 12.4.1 Global Monoclonal Antibodies Sales Forecast by Regions 2019-2025
- 12.4.2 Global Monoclonal Antibodies Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Monoclonal Antibodies. Industry analysis & Market Report on Monoclonal Antibodies is a syndicated market report, published as Global (United States, European Union and China) Monoclonal Antibodies Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Monoclonal Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
